The highest-leverage move in dental right now is not marketing or another associate

The highest leverage move available to dental practices right now isn't more marketing, new tech, adding operatories, or hiring another associate. Current conditions prove it's actually in recovering dormant revenue that's already sitting in the patient base.

Hygienist recruitment has been nearly impossible for three consecutive years and less than half of open positions are actually getting filled. When hygiene staffing is unstable the recall systems fracture, patients fall out of their cycle, follow-up stops happening consistently, and they quietly lapse. This is not a front desk problem but a matter of staffing instability which accumulates in the PMS over months and years without anyone ever formally quantifying what it's costing.

Busyness levels are down and chair availability is up. The capacity to see those lapsed patients is sitting there. So the operational gap and the scheduling gap exist simultaneously but almost nobody is connecting the two. Meanwhile, reimbursement rates aren't keeping pace with supply costs, equipment costs, or wages. Margin pressure is here and isn't going away, which means every dollar recovered from the existing patient base has a higher relative impact than chasing new patient volume through marketing spend. Fees are up too. The average production value per appointment has increased, which means each recovered lapsed patient is worth more than it was a year ago.

Lapsed recall, unscheduled treatment, and no-show patterns represent revenue that exists in the patient base but never converted to a scheduled appointment and never triggered a billing event. It doesn't appear in any financial report because it never became production. It lives in the PMS and it's hiding in plain sight until someone goes looking for it specifically, and systemically, and regularly. Not just seeing the numbers, but actually understanding why they are what they are, diagnosing how to really improve them, and the impact of this all on a deal.

For a practice approaching a transaction, whether to buy or sell, this is the gap between what the trailing financials show and what the practice was actually capable of producing. That gap doesn't disappear at close. It either gets documented and priced in before the deal, or it transfers silently to the buyer as unpriced upside.